Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words '5''-DEOXY-5-FLUOROURIDINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 134 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fujimoto-Ouchi, K; Tanaka, Y; Tominaga, T
      Schedule dependency of antitumor activity in combination therapy with capecitabine/5 '-deoxy-5-fluorouridine and docetaxel in breast cancer models

      CLINICAL CANCER RESEARCH
    2. Hori, T; Kodama, H; Nishimura, S; Hatano, T; Okamura, R; Fujii, K; Kudo, T; Inamoto, T; Sawai, K; Kobayashi, M; Ogawa, H; Yoshimura, N; Hiraoka, M
      A randomized study comparing oral and standard regimens for metastatic breast cancer

      ONCOLOGY REPORTS
    3. Sadahiro, S; Otani, Y; Oya, K; Ike, H; Shimada, H; Yamaguchi, S; Hiki, Y; Fujita, H; Mitomi, T
      Thymidine phosphorylase expression and effect of doxifluridine: A phase IIstudy

      ONCOLOGY REPORTS
    4. Sato, S; Yajima, A; Sasaki, H; Mizutani, K; Honjo, H; Yamamoto, K; Ozaki, M; Hasegawa, K; Kudo, T; Yakushiji, M; Hatae, M; Noda, K
      Prognostic value of thymidine phosphorylase immunostaining in patients with uterine cervical cancer treated concurrently with doxifluridine, radiotherapy and immunotherapy

      ONCOLOGY REPORTS
    5. Yamamoto, K; Noda, K; Hatae, M; Kudo, T; Hasegawa, K; Nishimura, R; Honjo, H; Yajima, A; Sato, S; Mizutani, K; Yakushiji, M; Terashima, Y; Ochiai, K; Sasaki, H; Ozaki, M
      Effects of concomitant use of doxifluridine, radiotherapy and immunotherapy in patients with advanced cervical cancer

      ONCOLOGY REPORTS
    6. Katsumata, K; Sumi, T; Yamashita, S; Takahashi, S; Mori, M; Baba, T; Murohashi, T; Nagashima, K; Ashizawa, T; Yamamoto, K; Koyanagi, Y; Katoh, K
      The significance of thymidine phosphorylase expression in colorectal cancer

      ONCOLOGY REPORTS
    7. Ishii, R; Takiguchi, N; Oda, K; Koda, K; Miyazaki, M
      Thymidine phosphorylase expression is useful in selecting adjuvant chemotherapy for stage III gastric cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    8. Takeda, Y; Yoshizaki, I; Nonaka, Y; Yanagie, H; Matsuzawa, A; Eriguchi, M
      Docetaxel alone or orally combined with 5-fluorouracil and its derivatives: effects on mouse mammary tumor cell line MM2 in vitro and in vivo

      ANTI-CANCER DRUGS
    9. Villalona-Calero, MA; Blum, JL; Jones, SE; Diab, S; Elledge, R; Khoury, P; Von Hoff, D; Kraynak, M; Moczygemba, J; Kromelis, P; Griffin, T; Rowinsky, EK
      A phase I and pharmacologic study of capecitabine and paclitaxel in breastcancer patients

      ANNALS OF ONCOLOGY
    10. Ueda, S; Yamaoka, K; Sawai, Y; Nakagawa, T
      Introduction of recirculatory analysis into portal and systemic concentration difference method

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    11. Ooi, K; Ohkubo, T; Higashigawa, M; Kawasaki, H; Kakito, H; Kagawa, Y; Kojima, M; Sakurai, M
      Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210ascites tumor following oral administration of 5-fluorouracil, UFT (Mixed compound of tegafur and uracil), carmofur and 5 '-deoxy-5-fluorouridine

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    12. Hiroyasu, S; Shiraishi, M; Samura, H; Tokashiki, H; Shimoji, H; Isa, T; Muto, Y
      Clinical relevance of the concentrations of both pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    13. Minari, Y; Nio, Y; Hirahara, N; Dong, M
      Heterogeneic distribution of thymidine phosphorylase between primary tumors and metastatic lesions of human pancreatic ductal carcinoma: implicationsfor the efficacy of chemotherapy with 5-FU or its derivatives

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    14. Ogawa, K; Konno, SI; Takebayashi, Y; Murayama, M; Shimakawa, T; Katsube, T; Naritaka, Y; Kajiwara, T; Aiba, M; Akiyama, SI
      Effect of intratumoral OK-432 administration on thymidine phosphorylase expression in human gastric carcinoma

      ANTICANCER RESEARCH
    15. Mata, JF; Garcia-Manteiga, JM; Lostao, MP; Fernandez-Veledo, S; Guillen-Gomez, E; Larrayoz, IM; Lloberas, J; Casado, FJ; Pastor-Anglada, M
      Role of the human concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5[prime]-deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug

      MOLECULAR PHARMACOLOGY
    16. Tsuruta, K; Okamoto, A; Egawa, N; Kamisawa, T; Karasawa, K; Takahashi, T
      Survival benefits of adjuvant chemotherapy with oral doxifluridine (5 '-DFUR) following radiotherapy in patients with unresectable pancreatic cancer

      JOURNAL OF SURGICAL ONCOLOGY
    17. Ueda, M; Terai, Y; Kumagai, K; Ueki, K; Kanemura, M; Ueki, M
      Correlation between thymidine phosphorylase expression and invasion phenotype in cervical carcinoma cells

      INTERNATIONAL JOURNAL OF CANCER
    18. Zhang, DK; Cao, DL; Russell, R; Pizzorno, G
      P53-dependent suppression of uridine phosphorylase gene expression throughdirect promoter interaction

      CANCER RESEARCH
    19. Yano, T; Takeo, S
      Thymidine phosphorylase activity in nonsmall cell lung carcinoma tissues

      CANCER
    20. Cuq, P; Rouquet, C; Evrard, A; Ciccolini, J; Vian, L; Cano, JP
      Fluoropyrimidine sensitivity of human MCF-7 breast cancer cells stably transfected with human uridine phosphorylase

      BRITISH JOURNAL OF CANCER
    21. Ciccolini, J; Peillard, L; Evrard, A; Cuq, P; Aubert, C; Pelegrin, A; Formento, P; Milano, G; Catalin, J
      Enhanced antitumor activity of 5-fluorouracil in combination with 2 '-deoxyinosine in human colorectal cell lines and human colon tumor xenografts

      CLINICAL CANCER RESEARCH
    22. van Triest, B; Pinedo, HM; Blaauwgeers, JLG; van Diest, PJ; Schoenmakers, PS; Voorn, DA; Smid, K; Hoekman, K; Hoitsma, HFW; Peters, GJ
      Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer

      CLINICAL CANCER RESEARCH
    23. Di Costanzo, F; Sdrobolini, A; Gasperoni, S
      Capecitabine, a new oral fluoropyrimidine for the treatment of colorectal cancer

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    24. Kurosumi, M; Tabei, T; Suemasu, K; Inoue, K; Kusawake, T; Sugamata, N; Higashi, Y
      Enhancement of immunohistochemical reactivity for thymidine phosphorylase in breast carcinoma cells after administration of docetaxel as a neoadjuvant chemotherapy in advanced breast cancer patients

      ONCOLOGY REPORTS
    25. Kondo, K; Sakamoto, J; Nakazato, H; Koike, A; Kitoh, T; Hachisuka, K; Saji, S; Yura, J; Nimura, Y; Hamajima, N; Katoh, K; Yamaguchi, A; Miya, K; Yamauchi, M; Mizuno, I; Nagino, M; Takagi, H
      A phase III randomized study comparing doxifluridine and 5-fluorouracil assupportive chemotherapy in advanced and recurrent gastric cancer

      ONCOLOGY REPORTS
    26. Takahashi, H; Maeda, Y; Watanabe, KI; Taguchi, K; Sasaki, F; Todo, S
      Correlation between elevated intratumoral thymidine phosphorylase and prognosis of node-positive breast carcinoma undergoing adjuvant doxifluridine treatment

      INTERNATIONAL JOURNAL OF ONCOLOGY
    27. Takahashi, Y; Mai, M; Taguchi, T; Urushizaki, I; Nishioka, K
      Prolonged stable disease effects survival in patients with solid gastric tumor: Analysis of phase II studies of doxifluridine

      INTERNATIONAL JOURNAL OF ONCOLOGY
    28. Takiguchi, N; Nakajima, N; Saitoh, N; Fujimoto, S; Nakazato, H
      A phase III randomized study comparing oral doxifluridine and oral 5-fluorouracil after curative resection of gastric cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    29. Shimma, N; Umeda, I; Arasaki, M; Murasaki, C; Masubuchi, K; Kohchi, Y; Miwa, M; Ura, M; Sawada, N; Tahara, H; Kuruma, I; Horii, I; Ishitsuka, H
      The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, capecitabine

      BIOORGANIC & MEDICINAL CHEMISTRY
    30. Osaki, M; Sakatani, T; Okamoto, E; Goto, E; Adachi, H; Ito, H
      Thymidine phosphorylase expression results in a decrease in apoptosis and increase in intratumoral microvessel density in human gastric carcinomas

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    31. Ueda, M; Kitaura, K; Kusada, O; Mochizuki, Y; Yamada, N; Terai, Y; Kumagai, K; Ueki, K; Ueki, M
      Regulation of dihydropyrimidine dehydrogenase and pyrimidine nucleoside phosphorylase activities by growth factors and subsequent effects on 5-fluorouracil sensitivity in tumor cells

      JAPANESE JOURNAL OF CANCER RESEARCH
    32. Schuller, J; Cassidy, J; Dumont, E; Roos, B; Durston, S; Banken, L; Utoh, M; Mori, K; Weidekamm, E; Reigner, B
      Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    33. Zeng, ZC; Tang, ZY; Wu, ZQ; Ma, ZC; Fan, J; Qin, LX; Zhou, J; Wang, JH; Wang, BL; Zhong, CS
      Phase I clinical trial of oral Furtulon and combined hepatic arterial chemoembolization and radiotherapy in unresectable primary liver cancers, including clinicopathologic study

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    34. Hata, K; Fujiwaki, R; Nakayama, K; Maede, Y; Fukumoto, M; Miyazaki, K
      Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: Correlation with angiogenesis and progression of the tumor

      ANTICANCER RESEARCH
    35. Ishitsuka, H
      Capecitabine: preclinical pharmacology studies

      INVESTIGATIONAL NEW DRUGS
    36. Budman, DR
      Capecitabine

      INVESTIGATIONAL NEW DRUGS
    37. Sobrero, A; Guglielmi, A; Grossi, F; Puglisi, F; Aschele, C
      Mechanism of action of fluoropyrimidines: Relevance to the new developments in colorectal cancer chemotherapy

      SEMINARS IN ONCOLOGY
    38. Hata, K; Fujiwaki, R; Maede, Y; Nakayama, K; Fukumoto, M; Miyazaki, K
      Expression of thymidine phosphorylase in epithelial ovarian cancer: Correlation with angiogenesis, apoptosis, and ultrasound-derived peak systolic velocity

      GYNECOLOGIC ONCOLOGY
    39. Lencioni, M; Falcone, A; Allegrini, G; Pfanner, E; Masi, G; Brunetti, I; Di Marsico, R; Fontana, E; Orlandini, C; Stampino, CG; Bartolozzi, C; Conte, PF
      Oral doxifluridine in advanced hepatocellular carcinoma: A phase II study

      ONCOLOGY
    40. Amano, M; Sekimoto, M; Monden, T; Tomita, N; Ohue, M; Haba, A; Sakita, I; Tamaki, Y; Monden, M
      Selective augmentations of intratumoral 5-fluorouracil concentration by local immunotherapy with OK-432 and fibrinogen

      DISEASES OF THE COLON & RECTUM
    41. Hussey, HJ; Todorov, PT; Field, WN; Inagaki, N; Tanaka, Y; Ishitsuka, H; Tisdale, MJ
      Effect of a fluorinated pyrimidine on cachexia and tumour growth in murinecachexia models: relationship with a proteolysis inducing factor

      BRITISH JOURNAL OF CANCER
    42. Sawada, N; Ishikawa, T; Sekiguchi, F; Tanaka, Y; Ishitsuka, H
      X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (xeloda) in human cancer xenografts

      CLINICAL CANCER RESEARCH
    43. Kakeji, Y; Maehara, Y; Shibahara, K; Hasuda, S; Oshiro, T; Baba, H; Kohnoe, S; Sugimachi, K
      Heterogeneity and clinical role of thymidine phosphorylase activity in gastric cancer

      ONCOLOGY REPORTS
    44. Kakeji, Y; Maehara, Y; Tomoda, M; Kabashima, A; Oda, S; Ooshiro, T; Baba, H; Kohnoe, S; Sugimachi, K
      Thymidine phosphorylase activity and angiogenesis in gastric cancer

      ONCOLOGY REPORTS
    45. Villalona-Calero, MA; Weiss, GR; Burris, HA; Kraynak, M; Rodrigues, G; Drengler, RL; Eckhardt, SG; Reigner, B; Moczygemba, J; Burger, HU; Griffin, T; Von Hoff, DD; Rowinsky, EK
      Phase I and pharmacokinetic study of the oral fluoropyrimidine capecitabine in combination with paclitaxel in patients with advanced solid malignancies

      JOURNAL OF CLINICAL ONCOLOGY
    46. Goto, A; Osaki, M; Kiyonari, H; Ito, H
      Partial enhancement of hyprethermia-induced apoptosis by increasing enzymatic activity of thymidine phosphorylase in human gastric carcinoma cell lines

      BIOMEDICAL RESEARCH-TOKYO
    47. Morita, T; Tokue, A
      Biomodulation of 5-fluorouracil by interferon-alpha in human renal carcinoma cells: relationship to the expression of thymidine phosphorylase

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    48. Ikemoto, S; Sugimura, K; Wada, S; Yasumoto, R; Yamamoto, K; Kishimoto, T
      Augmentation of antitumor activity of 5 '-deoxy-5-fluorouridine by thymosin fraction 5 in mouse bladder cancer cells in vitro and in vivo

      CANCER LETTERS
    49. Zampino, MG; Colleoni, M; Bajetta, E; Stampino, CG; Guenzi, A; de Braud, F
      Pharmacokinetics of oral doxifluridine in patients with colorectal cancer

      TUMORI
    50. Yang, QF; Shan, L; Yoshimura, G; Taniguchi, E; Suzuma, T; Nakamura, Y; Nakamura, M; Utsunomiya, H; Tang, WH; Sakurai, T; Kakudo, K
      Thymidine phosphorylase expression in invasive carcinoma: Correlations with clinicopathologic variables and in vitro chemosensitivity to 5-fluorouracil

      ANTICANCER RESEARCH
    51. Hata, K; Takebayashi, W; Iida, K; Fujiwaki, R; Fukumoto, M; Miyazaki, K
      Expression of thymidine phosphorylase in human cervical cancer

      ANTICANCER RESEARCH
    52. Ogawa, T; Ohwada, S; Sato, Y; Izumi, M; Nakamura, S; Takeyoshi, I; Kawashima, Y; Ohya, T; Koyama, T; Morishita, Y
      Effects of 5 '-DFUR and lentinan on cytokines and PyNPase against AH66 ascites hepatoma in rats

      ANTICANCER RESEARCH
    53. Ishitsuka, H; Shimma, N; Horii, I
      Discovery and development of novel anticancer drug capecitabine

      YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
    54. Koizumi, W; Saigenji, K; Nakamaru, N; Okayasu, I; Kurihara, M
      Prediction of response to 5 '-deoxy-5-fluorouridine (5 '-DFUR) in patientswith inoperable advanced gastric cancer by immunostaining of thymidine phosphorylase platelet-derived endothelial cell growth factor

      ONCOLOGY
    55. Cao, DL; Nimmakayalu, MA; Wang, FY; Zhang, DK; Handschumacher, RE; Bray-Ward, P; Pizzorno, G
      Genomic structure, chromosomal mapping, and promoter region analysis of murine uridine phosphorylase gene

      CANCER RESEARCH
    56. Yoshikawa, T; Suzuki, K; Kobayashi, O; Sairenji, M; Motohashi, H; Tsuburaya, A; Nakamura, Y; Shimizu, A; Yanoma, S; Noguchi, Y
      Thymidine phosphorylase/platelet-derived endothelial cell growth factor isupregulated in advanced solid types of gastric cancer

      BRITISH JOURNAL OF CANCER
    57. Yamagata, M; Mori, M; Mimori, K; Mafune, KI; Tanaka, Y; Ueo, H; Akiyoshi, T
      Expression of pyrimidine nucleoside phosphorylase mRNA plays an important role in the prognosis of patients with oesophageal cancer

      BRITISH JOURNAL OF CANCER
    58. NAKATA B; CHUNG KHY; KATO Y; YAMASHITA Y; ONODA N; MAEDA K; SOWA M
      THYMIDINE PHOSPHORYLASE-ACTIVITY IN TUMOR CORRELATES WITH VENOUS INVASION

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    59. REIGNER B; VERWEIJ J; DIRIX L; CASSIDY J; TWELVES C; ALLMAN D; WEIDEKAMM E; ROOS B; BANKEN L; UTOH M; OSTERWALDER B
      EFFECT OF FOOD ON THE PHARMACOKINETICS OF CAPECITABINE AND ITS METABOLITES FOLLOWING ORAL-ADMINISTRATION IN CANCER-PATIENTS

      Clinical cancer research
    60. REIGNER B; VERWEIJ J; DIRIX L; CASSIDY J; TWELVES C; ALLMAN D; WEIDEKAMM E; ROOS B; BANKEN L; UTOH M; OSTERWALDER B
      EFFECT OF FOOD ON THE PHARMACOKINETICS OF CAPECITABINE AND ITS METABOLITES FOLLOWING ORAL-ADMINISTRATION IN CANCER-PATIENTS

      Clinical cancer research
    61. SAWADA N; ISHIKAWA T; FUKASE Y; NISHIDA M; YOSHIKUBO T; ISHITSUKA H
      INDUCTION OF THYMIDINE PHOSPHORYLASE-ACTIVITY AND ENHANCEMENT OF CAPECITABINE EFFICACY BY TAXOL TAXOTERE IN HUMAN CANCER XENOGRAFTS/

      Clinical cancer research
    62. SAWADA N; ISHIKAWA T; FUKASE Y; NISHIDA M; YOSHIKUBO T; ISHITSUKA H
      INDUCTION OF THYMIDINE PHOSPHORYLASE-ACTIVITY AND ENHANCEMENT OF CAPECITABINE EFFICACY BY TAXOL TAXOTERE IN HUMAN CANCER XENOGRAFTS/

      Clinical cancer research
    63. NAGAOKA H; IINO Y; TAKEI H; MORISHITA Y
      PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR THYMIDINE PHOSPHORYLASE EXPRESSION IN MACROPHAGES CORRELATES WITH TUMOR ANGIOGENESIS AND PROGNOSIS IN INVASIVE BREAST-CANCER

      International journal of oncology
    64. MIWA M; URA M; NISHIDA M; SAWADA N; ISHIKAWA T; MORI K; SHIMMA N; UMEDA I; ISHITSUKA H
      DESIGN OF A NOVEL ORAL FLUOROPYRIMIDINE CARBAMATE, CAPECITABINE, WHICH GENERATES 5-FLUOROURACIL SELECTIVELY IN TUMORS BY ENZYMES CONCENTRATED IN HUMAN LIVER AND CANCER-TISSUE

      European journal of cancer
    65. NERI B; GEMELLI MT; PANTALONE D; PERNICE ML; AGOSTINO I; SCATIZZI M; SILIANI GM; BARTOLINI P; ANDREOLI F
      RESULTS OF LEUCOVORIN AND DOXIFLURIDINE ORAL REGIMEN IN THE TREATMENTOF METASTATIC COLORECTAL-CANCER

      Anti-cancer drugs
    66. GU JA; YUASA H; HAYASHI Y; WATANABE J
      FIRST-PASS METABOLISM OF 5-FLUOROURACIL IN THE PERFUSED RAT SMALL-INTESTINE

      Biological & pharmaceutical bulletin
    67. ISHIKAWA T; FUKASE Y; YAMAMOTO T; SEKIGUCHI F; ISHITSUKA H
      ANTITUMOR ACTIVITIES OF A NOVEL FLUOROPYRIMIDINE, N-4-PENTYLOXYCARBONYL-5'-DEOXY-5-FLUOROCYTIDINE (CAPECITABINE)

      Biological & pharmaceutical bulletin
    68. OKAMURA A; OHMURA Y; ISLAM MM; TAGAWA M; HORITSU K; MORIYAMA Y; FUJIMURA S
      INCREASED HEPATIC NICOTINAMIDE N-METHYLTRANSFERASE ACTIVITY AS A MARKER OF CANCER CACHEXIA IN MICE BEARING COLON-26 ADENOCARCINOMA

      Japanese journal of cancer research
    69. Ueda, M; Fujii, H; Yoshizawa, K; Kumagai, K; Ueki, K; Terai, Y; Yanagihara, T; Ueki, M
      Effects of sex steroids and growth factors on invasive activity and 5 '-deoxy-5-fluorouridine sensitivity in ovarian adenocarcinoma OMC-3 cells

      JAPANESE JOURNAL OF CANCER RESEARCH
    70. MACKEAN M; PLANTING A; TWELVES C; SCHELLENS J; ALLMAN D; OSTERWALDER B; REIGNER B; GRIFFIN T; KAYE S; VERWEIJ J
      PHASE-I AND PHARMACOLOGICAL STUDY OF INTERMITTENT TWICE-DAILY ORAL-THERAPY WITH CAPECITABINE IN PATIENTS WITH ADVANCED AND OR METASTATIC CANCER/

      Journal of clinical oncology
    71. ZAMBONIN CG; MASTROLITTI S; PALMISANO F
      DETERMINATION OF N-3-METHYL-5'-DEOXY-5-FLUOROURIDINE, A NOVEL METABOLITE OF DOXIFLURIDINE, IN BODY-FLUIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

      Journal of pharmaceutical and biomedical analysis
    72. ZAMBONIN CG; ARESTA A; GRANO M
      IN-VITRO TOXICITY OF N-3-METHYL-5'-DEOXY-5-FLUOROURIDINE, A NOVEL METABOLITE OF DOXIFLURIDINE - A BIOANALYTICAL INVESTIGATION

      Journal of pharmaceutical and biomedical analysis
    73. SAWAI Y; YAMAOKA K; NAKAGAWA T
      EFFECT OF COADMINISTERED URIDINE ON INTESTINAL FIRST-PASS METABOLISM OF 5'-DEOXY-5-FLUOROURIDINE IN CONSCIOUS RATS - AN EVALUATION BY METHOD OF PORTAL-SYSTEMIC CONCENTRATION DIFFERENCE

      Pharmaceutical research
    74. SHIBATA J; MURAKAMI K; ABE M; HASHIMOTO A; UTSUGI T; FUKUSHIMA M; YAMADA Y
      LIFE-PROLONGING EFFECT OF ANTITUMOR AGENTS ON POSTOPERATIVE ADJUVANT THERAPY IN THE LUNG SPONTANEOUS METASTASIS MODEL IN MICE

      Anticancer research
    75. ISHIKAWA T; SEKIGUCHI F; FUKASE Y; SAWADA N; ISHITSUKA H
      POSITIVE CORRELATION BETWEEN THE EFFICACY OF CAPECITABINE AND DOXIFLURIDINE AND THE RATIO OF THYMIDINE PHOSPHORYLASE TO DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITIES IN TUMORS IN HUMAN CANCER XENOGRAFTS

      Cancer research
    76. LEEK RD; LANDERS R; FOX SB; NG F; HARRIS AL; LEWIS CE
      ASSOCIATION OF TUMOR-NECROSIS-FACTOR-ALPHA AND ITS RECEPTORS WITH THYMIDINE PHOSPHORYLASE EXPRESSION IN INVASIVE BREAST-CARCINOMA

      British Journal of Cancer
    77. KOUKOURAKIS MI; GIATROMANOLAKI A; KAKOLYRIS S; OBYRNE KJ; APOSTOLIKAS N; SKARLATOS J; GATTER KC; HARRIS AL
      DIFFERENT PATTERNS OF STROMAL AND CANCER CELL THYMIDINE PHOSPHORYLASEREACTIVITY IN NON-SMALL-CELL LUNG-CANCER - IMPACT ON TUMOR NEOANGIOGENESIS AND SURVIVAL

      British Journal of Cancer
    78. ARELLANO M; MALETMARTINO M; MARTINO R; GIRES P
      THE ANTICANCER DRUG 5-FLUOROURACIL IS METABOLIZED BY THE ISOLATED-PERFUSED RAT-LIVER AND IN RATS INTO HIGHLY TOXIC FLUOROACETATE

      British Journal of Cancer
    79. ISHIKAWA T; UTOH M; SAWADA N; NISHIDA M; FUKASE Y; SEKIGUCHI F; ISHITSUKA H
      TUMOR SELECTIVE DELIVERY OF 5-FLUOROURACIL BY CAPECITABINE, A NEW ORAL FLUOROPYRIMIDINE CARBAMATE, IN HUMAN CANCER XENOGRAFTS

      Biochemical pharmacology
    80. STEVENSON DP; COLLINS WP; FARZANEH F; HATA K; MIYAZAKI K
      THYMIDINE PHOSPHORYLASE-ACTIVITY AND PRODRUG EFFECTS IN A 3-DIMENSIONAL MODEL OF ANGIOGENESIS - IMPLICATIONS FOR THE TREATMENT OF OVARIAN-CANCER

      The American journal of pathology
    81. KUBOTA Y; MIURA T; MORIYAMA M; NOGUCHI S; MATSUZAKI J; TAKEBAYASHI S; HOSAKA M
      THYMIDINE PHOSPHORYLASE-ACTIVITY IN HUMAN BLADDER-CANCER - DIFFERENCEBETWEEN SUPERFICIAL AND INVASIVE CANCER

      Clinical cancer research
    82. HIDESHIMA T; YAMASHITA J; MAEKAWA T; SAKAI T; BABA M; OGAWA M; SHIRAKUSA T
      THE INFLUENCE OF PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE-ACTIVITY ON METASTASIS OF BREAST-CANCER

      Oncology Reports
    83. SAJI S; TOI M; YAMAMOTO Y; TOMINAGA T
      THE INCREASE OF APOPTOSIS AND THE DECREASE OF PROLIFERATION BY ANGIOGENESIS INHIBITOR IN RAT MAMMARY-TUMORS

      Oncology Reports
    84. MIMORI K; MORI M; SHIRAISHI T; HARAGUCHI M; UEO H; AKIYOSHI T
      CLINICAL-SIGNIFICANCE OF PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE IN COLORECTAL-CARCINOMA

      International journal of oncology
    85. BAJETTA E; DIBARTOLOMEO M; SOMMA L; DELVECCHIO M; ARTALE S; ZUNINO F; BIGNAMI P; MAGNANI E; BUZZONI R
      DOXIFLURIDINE IN COLORECTAL-CANCER PATIENTS RESISTANT TO 5-FLUOROURACIL (5-FU) CONTAINING REGIMENS

      European journal of cancer
    86. ZAMBONIN CG; MASTROLITTI S; PALMISANO F
      DERIVATIZATION REACTIONS FOR GAS-CHROMATOGRAPHY MASS-SPECTROMETRY DETERMINATION OF N-3-METHYL-5'-DEOXY-5-FLUOROURIDINE

      Rapid communications in mass spectrometry
    87. SCHOTT H; LUDWIG PS; GANSAUGE F; GANSAUGE S; SCHWENDENER RA
      SYNTHESIS AND IN-VITRO ANTITUMOR-ACTIVITY OF -(3'-]-5')-2'-DEOXY-5-FLUORO-N-4-OCTADECYLCYTIDINE - A NEW AMPHIPHILIC DINUCLEOSIDE PHOSPHATE

      Liebigs Annalen
    88. HAMADA A; NAKANO M; SHIMIDZU S; HASEGAWA T; KAWAGUCHI T
      INHIBITION OF 5'-DEOXY-5-FLUOROURIDINE PHOSPHOROLYSIS BY ACYCLOTHYMIDINE IN TUMOR-CELL HOMOGENATES

      Biological & pharmaceutical bulletin
    89. SAWAI Y; YAMAOKA K; ITO T; NAKAGAWA T
      SIMULTANEOUS EVALUATION OF INTESTINAL-ABSORPTION AND HEPATIC EXTRACTION OF 5-FLUOROURACIL USING PORTAL-SYSTEMIC CONCENTRATION DIFFERENCE BYSHORT-PERIOD DOUBLE DOSING IN A SINGLE CONSCIOUS RAT

      Biological & pharmaceutical bulletin
    90. MIDORO K; GOTOH K; HOUKAN T; YUKISHIGE K; FUJIWARA K; OOTSU K
      ANTITUMOR EFFECTS OF 5'-DEOXY-5-FLUOROURIDINE IN COMBINATION WITH RECOMBINANT HUMAN INTERLEUKIN-2 ON MURINE COLON-CARCINOMA-26

      Japanese journal of cancer research
    91. IKEDA K; SAITOH S; SUZUKI Y; KOIDA I; TSUBOTA A; KOBAYASHI M; ARASE Y; CHAYAMA K; MURASHIMA N; KUMADA H
      A PROSPECTIVE RANDOMIZED ADMINISTRATION OF 5'-DEOXY-5-FLUOROURIDINE AS ADJUVANT CHEMOTHERAPY FOR HEPATOCELLULAR-CARCINOMA TREATED WITH TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION

      American journal of clinical oncology
    92. TAZAWA K; SAKAMOTO T; KUROKI Y; YAMASHITA I; OKAMOTO M; KATUYAMA S; FUJIMAKI M
      INHIBITORY EFFECTS OF FLUORINATED PYRIMIDINES, 5'-DFUR, UFT AND T-506, IN A MODEL OF HEPATIC METASTASIS OF MOUSE COLON-26 ADENOCARCINOMA - ASSESSMENT OF INHIBITORY ACTIVITY AND ADVERSE REACTIONS AT THE MAXIMUMTOLERATED DOSE

      Clinical & experimental metastasis
    93. OHWADA S; OGAWA T; IZUMI M; INOUE T; TESHIGAWARA O; IKEYA T; KUSABA T; ROPPONGI T; IINO Y; MORISHITA Y
      EFFECTS OF 5'-DFUR AND OK-432 ON CYTOKINES AND THYMIDINE PHOSPHORYLASE IN TUMOR-TISSUE OF GASTRIC-CANCER PATIENTS

      Anticancer research
    94. DOUSSISANAGNOSTOPOULOU IA; REMADI S; TURLEY H; GINDRE P; COMLEY M; BORISCH B; GATTER KC
      PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR THYMIDINE PHOSPHORYLASE IMMUNOHISTOCHEMICAL EXPRESSION IN LYMPHOID-TISSUE AND LYMPHOID MALIGNANCIES

      Human pathology
    95. KISSEL J; BRIX G; BELLEMANN ME; STRAUSS LG; DIMITRAKOPOULOUSTRAUSS A; PORT R; HABERKORN U; LORENZ WJ
      PHARMACOKINETIC ANALYSIS OF 5-[F-18]FLUOROURACIL TISSUE CONCENTRATIONS MEASURED WITH POSITRON EMISSION TOMOGRAPHY IN PATIENTS WITH LIVER METASTASES FROM COLORECTAL ADENOCARCINOMA

      Cancer research
    96. GRIFFITHS L; STRATFORD IJ
      PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR THYMIDINE PHOSPHORYLASE IN TUMOR-GROWTH AND RESPONSE TO THERAPY

      British Journal of Cancer
    97. KOUKOURAKIS MI; GIATROMANOLAKI A; OBYRNE KJ; COMLEY M; WHITEHOUSE RM; TALBOT DC; GATTER KC; HARRIS AL
      PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR EXPRESSION CORRELATESWITH TUMOR ANGIOGENESIS AND PROGNOSIS IN NON-SMALL-CELL LUNG-CANCER

      British Journal of Cancer
    98. KATO Y; MATSUKAWA S; MURAOKA R; TANIGAWA N
      ENHANCEMENT OF DRUG-SENSITIVITY AND A BYSTANDER EFFECT IN PC-9 CELLS TRANSFECTED WITH A PLATELET-DERIVED ENDOTHELIAL CELL GROWTH-FACTOR THYMIDINE PHOSPHORYLASE CDNA

      British Journal of Cancer
    99. HAMADA A; FUKUSHIMA S; SANEYOSHI M; SHIMIZU S; KAWAGUCHI T; NAKANO M
      MODULATION OF THE PHARMACOKINETICS OF 5'-DEOXY-5-FLUOROURIDINE AND 5-FLUOROURACIL IN RATS BY ORAL COADMINISTRATION OF ACYCLOTHYMIDINE

      Biological & pharmaceutical bulletin
    100. NISHIDA M; HINO A; MORI K; MATSUMOTO T; YOSHIKUBO T; ISHITSUKA H
      PREPARATION OF ANTI-HUMAN THYMIDINE PHOSPHORYLASE MONOCLONAL-ANTIBODIES USEFUL FOR DETECTING THE ENZYME LEVELS IN TUMOR-TISSUES

      Biological & pharmaceutical bulletin


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 17:07:39